Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ELTXELTX
Showing 8 of 13 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ELICIO THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 311,354 shares of ELTX (ELICIO THERAPEUTICS INC), worth $1.2M as of 2026-Q2. The position was increased (+130.3% shares). ELTX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$1.2M

Current Shares

311,354

Total Value Change

+$857,559

Total Shares Change

+239,780

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
311,354
+130.3%
$1.2M0.0%$3.91
41
2026-Q1
Increased
135,164
+2.0%
$1.4M0.0%$12.50
26
2025-Q4
Increased
132,518
+2.2%
$1.1M0.0%$7.91
26
2025-Q3
Increased
129,686
+7.3%
$1.4M0.0%$10.84
27
2025-Q2
Increased
120,831
+56.0%
$932,8760.0%$7.90
35
2025-Q1
Increased
77,467
+9.5%
$477,2550.0%$7.79
18
2024-Q4
Decreased
70,721
-1.2%
$346,5800.0%$5.00
0
2024-Q3
Increased
71,574
+0.1%
$360,0550.0%$5.06
16

Other major holders of ELTX: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used